ConductScience.org, home

Paper33477635

Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma.

Muzaffar J and 3 others. Cancers (Basel), 2021. Cited by 115 papers, by iCite.

Cite this record

ConductScience Library. Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma. Papers, record 33477635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33477635

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2021
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
115
iCite
Relative citation ratio, by iCite
7.6
iCite
Revised in PubMed
2024-03-30
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Muzaffar JJameel
2Bari SShahla
3Kirtane KKedarhttps://orcid.org/0000-0003-1302-9577
4Chung CHChristine H

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References101

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
127247226Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial.Lancet Oncol2016https://conductscience.org/library/papers/27247226PubMed
225395239Incidence trends of human papillomavirus-related head and neck cancer in Taiwan, 1995-2009.Int J Cancer2015https://conductscience.org/library/papers/25395239PubMed
328855542Microbial Communities Associated with Primary and Metastatic Head and Neck Squamous Cell Carcinoma - A High Fusobacterial and Low Streptococcal Signature.Sci Rep2017https://conductscience.org/library/papers/28855542PubMed
429147608The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis.Oncoimmunology2017https://conductscience.org/library/papers/29147608PubMed
527718784Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck.N Engl J Med2016https://conductscience.org/library/papers/27718784PubMed
623817919Cigarette, cigar, and pipe smoking and the risk of head and neck cancers: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.Am J Epidemiol2013https://conductscience.org/library/papers/23817919PubMed
728029303
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.
J Clin Oncol2017https://conductscience.org/library/papers/28029303PubMed
823414589
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial.
Lancet Oncol2013https://conductscience.org/library/papers/23414589PubMed
920697079Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.J Clin Oncol2010https://conductscience.org/library/papers/20697079PubMed
1031308358Clinical update on head and neck cancer: molecular biology and ongoing challenges.Cell Death Dis2019https://conductscience.org/library/papers/31308358PubMed
1126402479Oncologic Outcomes After Transoral Robotic Surgery: A Multi-institutional Study.JAMA Otolaryngol Head Neck Surg2015https://conductscience.org/library/papers/26402479PubMed
1225631445Comprehensive genomic characterization of head and neck squamous cell carcinomas.Nature2015https://conductscience.org/library/papers/25631445PubMed
1329467336Frameshift events predict anti-PD-1/L1 response in head and neck cancer.JCI Insight2018https://conductscience.org/library/papers/29467336PubMed
1426359337Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.Science2015https://conductscience.org/library/papers/26359337PubMed
1516161069Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501).Head Neck2005https://conductscience.org/library/papers/16161069PubMed
1621224273Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions.Int J Epidemiol2011https://conductscience.org/library/papers/21224273PubMed
1725765070Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.Science2015https://conductscience.org/library/papers/25765070PubMed
1819276448E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells.J Natl Cancer Inst2009https://conductscience.org/library/papers/19276448PubMed
1924583792Phase I dendritic cell p53 peptide vaccine for head and neck cancer.Clin Cancer Res2014https://conductscience.org/library/papers/24583792PubMed
2020878955Trends in head and neck cancer incidence in Denmark, 1978-2007: focus on human papillomavirus associated sites.Int J Cancer2011https://conductscience.org/library/papers/20878955PubMed

See all 101 referencesDownload CSV of references

Cited by90

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.

PMIDTitleJournalYearIn PapersSource
42924143Heat shock factor 1 promotes cell migration and predicts poor prognosis in oral squamous cell carcinoma.J Dent Sci2026https://conductscience.org/library/papers/42924143PubMed
42374269Nano-silymarin combined with methylene blue photodynamic therapy versus monotherapies of head and neck squamous cell carcinoma: in-vitro study.BMC Cancer2026https://conductscience.org/library/papers/42374269PubMed
42327668Efficacy and safety of PD-1 inhibitors in recurrent or metastatic squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.Oncol Rev2026https://conductscience.org/library/papers/42327668PubMed
42166302Clinical and economic burden of recurrence among older patients with locoregionally advanced head and neck squamous cell carcinoma in the United States.J Manag Care Spec Pharm2026https://conductscience.org/library/papers/42166302PubMed
42115274Integrated bioinformatics approaches and expression assays identified a potential prognostic biomarker in oral squamous cell carcinoma.Sci Rep2026https://conductscience.org/library/papers/42115274PubMed
41940897Unraveling the molecular landscape: an overview on gene expression, epigenetic alterations, and therapeutic challenges in head and neck squamous cell carcinoma.Mol Genet Genomics2026https://conductscience.org/library/papers/41940897PubMed
41890969Insufficient erythrocyte-derived S1P: A pathogenic driver and diagnostic biolipid for tumor progression.iScience2026https://conductscience.org/library/papers/41890969PubMed
41683568TRPM2 Channel Involvement in the Hesperidin-Mediated Potentiation of Cisplatin's Antitumor Action in Laryngeal Carcinoma Cells.Int J Mol Sci2026https://conductscience.org/library/papers/41683568PubMed
41668805Circular RNA hsa-circ-0001030 suppresses proliferation and cisplatin tolerance in TSCC via interaction with PKM2.Cancer Drug Resist2026https://conductscience.org/library/papers/41668805PubMed
41612054Impact of the surgery to radiotherapy interval on oncological outcomes in squamous cell carcinoma of the oral tongue.Discov Oncol2026https://conductscience.org/library/papers/41612054PubMed
41259290
Inverse Correlation between Endoplasmic Reticulum Stress Intensity and Antitumor Immune Response with Ruthenium(II)-Based Photosensitizers for the Photodynamic Therapy of Head and Neck Squamous Cell Carcinoma.
J Med Chem2025https://conductscience.org/library/papers/41259290PubMed
41222766Identification of 5mC regulatory factors mediating methylation patterns and prognosis models in head and neck squamous cell carcinoma.Discov Oncol2025https://conductscience.org/library/papers/41222766PubMed
41178481A systematic review and network meta-analysis of therapies for locally advanced head and neck squamous cell carcinoma with different HPV status.Acta Otorhinolaryngol Ital2025https://conductscience.org/library/papers/41178481PubMed
41083026Clinically Interpretable Survival Risk Stratification in Head and Neck Cancer Using Bayesian Networks and Markov Blankets.Int J Radiat Oncol Biol Phys2026https://conductscience.org/library/papers/41083026PubMed
40985049CRISPR Screens Identify PIK3C2A as a Novel Mediator of EGFR Inhibitor Resistance in Head and Neck Squamous Cell Carcinoma.Head Neck2026https://conductscience.org/library/papers/40985049PubMed
40877432The antitumor effect of tlr4 inhibition in head and neck cancer cell lines.Sci Rep2025https://conductscience.org/library/papers/40877432PubMed
40752846The influence of soluble epoxide hydrolase inhibition and their PUFA-derived epoxides in osteoblast bone metabolism: an in vitro study.Biochim Biophys Acta Mol Cell Biol Lipids2025https://conductscience.org/library/papers/40752846PubMed
40597034VEGFA (rs1570360, rs699947, rs3025033, rs2146323, rs3024997) genotypes in patients with laryngeal squamous cell carcinoma.BMC Cancer2025https://conductscience.org/library/papers/40597034PubMed
40538851Real-world treatment patterns and survival outcomes in patients with locally advanced squamous cell carcinoma of the head and neck in Germany using claims data.Front Oncol2025https://conductscience.org/library/papers/40538851PubMed
40474706Immunotherapy in recurrent/metastatic head and neck squamous cell carcinoma: PD-L1 and beyond.Pathologica2025https://conductscience.org/library/papers/40474706PubMed

See all 90 cited byDownload CSV of cited by

Genes15

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33477635

GET https://conductscience.org/api/papers/v1/33477635/references?page=2